Sopharma AD operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other
drug stores in Europe:
Georgia Healthcare Group PLC
of the United Kingdom
sales of £228.69 million [US$285.51 million]
of which 60%
Aptechnaya set' 36,6' PAO
(48.25 billion Russian Rubles [US$726.69 million]
of which 100%
was Pharmaceuticals), and
Farmaceutica Remedia SA
based in Romania
(351.23 million Romanian Leu [US$85.37 million]
Sopharma AD reported sales of 1.03 billion Bulgarian Lev (US$593.49 million)
December of 2017.
increase of 15.8%
versus 2016, when the company's sales were 885.38 million Bulgarian Lev.
Sales of Distribution of Pharmaceutical Products saw an increase
20.7% in 2017, from
628.08 million Bulgarian Lev to 757.98 million Bulgarian Lev.
Not all segments of Sopharma AD experienced an increase in sales in 2017:
sales of Other Business Segment fell 36.9% to 16.29 million Bulgarian Lev.
(However, this segment's sales were only a very small portion of the company's overall sales).